<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000579913">
  <TermName>arzoxifene hydrochloride</TermName>
  <TermPronunciation>(ar-ZOK-sih-feen HY-droh-KLOR-ide)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of osteoporosis and breast cancer. Arzoxifene hydrochloride is made in the laboratory and binds to estrogen receptors in the body. It is a type of selective estrogen receptor modulator (SERM). Also called LY353381 hydrochloride.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000720578" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;arzoxifene hydrochloride&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000720577" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;clorhidrato de arzoxifeno&quot;" language="es" id="_4"/>
  <SpanishTermName>clorhidrato de arzoxifeno</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de la osteoporosis y el cáncer de mama. El clorhidrato de arzoxifeno se produce en el laboratorio; se une a los receptores de estrógeno del cuerpo. Es un tipo de modulador selectivo del receptor de estrógenos (MSRE). También se llama clorhidrato de LY353381.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2007-12-14</DateFirstPublished>
  <DateLastModified>2008-03-31</DateLastModified>
</GlossaryTerm>
